Alzheimer's Disease and Vascular Aging: JACC Focus Seminar
- PMID: 32130930
- PMCID: PMC8046164
- DOI: 10.1016/j.jacc.2019.10.062
Alzheimer's Disease and Vascular Aging: JACC Focus Seminar
Abstract
Alzheimer's disease, the leading cause of dementia in the elderly, is a neurodegenerative condition characterized by accumulation of amyloid plaques and neurofibrillary tangles in the brain. However, age-related vascular changes accompany or even precede the development of Alzheimer's pathology, raising the possibility that they may have a pathogenic role. This review provides an appraisal of the alterations in cerebral and systemic vasculature, the heart, and hemostasis that occur in Alzheimer's disease and their relationships to cognitive impairment. Although the molecular pathogenesis of these alterations remains to be defined, amyloid-β is a likely contributor in the brain as in the heart. Collectively, the evidence suggests that vascular pathology is a likely pathogenic contributor to age-related dementia, including Alzheimer's disease, inextricably linked to disease onset and progression. Consequently, the contribution of vascular factors should be considered in preventive, diagnostic, and therapeutic approaches to address one of the major health challenges of our time.
Keywords: atherosclerosis; blood-brain barrier; cerebral blood flow; dementia; hypertension; vascular dysfunction.
Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.
Figures
Similar articles
-
Involvement of cerebrovascular abnormalities in the pathogenesis and progression of Alzheimer's disease: an adrenergic approach.Aging (Albany NY). 2021 Sep 3;13(17):21791-21806. doi: 10.18632/aging.203482. Epub 2021 Sep 3. Aging (Albany NY). 2021. PMID: 34479211 Free PMC article. Review.
-
Systemic infection exacerbates cerebrovascular dysfunction in Alzheimer's disease.Brain. 2021 Jul 28;144(6):1869-1883. doi: 10.1093/brain/awab094. Brain. 2021. PMID: 33723589 Free PMC article.
-
The Alzheimer's Disease Amyloid-Beta Hypothesis in Cardiovascular Aging and Disease: JACC Focus Seminar.J Am Coll Cardiol. 2020 Mar 3;75(8):952-967. doi: 10.1016/j.jacc.2019.12.033. J Am Coll Cardiol. 2020. PMID: 32130931 Free PMC article. Review.
-
Cerebral hypoperfusion and glucose hypometabolism: Key pathophysiological modulators promote neurodegeneration, cognitive impairment, and Alzheimer's disease.J Neurosci Res. 2017 Apr;95(4):943-972. doi: 10.1002/jnr.23777. Epub 2016 Jun 27. J Neurosci Res. 2017. PMID: 27350397 Review.
-
Pathological alterations of the cerebral microvasculature in Alzheimer's disease and related dementing disorders.Acta Neuropathol. 1994;87(5):469-80. doi: 10.1007/BF00294173. Acta Neuropathol. 1994. PMID: 8059599
Cited by
-
Mitochondrial calcium uniporter promotes kidney aging in mice through inducing mitochondrial calcium-mediated renal tubular cell senescence.Acta Pharmacol Sin. 2024 May 24. doi: 10.1038/s41401-024-01298-5. Online ahead of print. Acta Pharmacol Sin. 2024. PMID: 38789496
-
Carotid-femoral pulse wave velocity score, an estimator of cognitive performance in the elderly: results from the Toledo Study for Healthy Aging.Geroscience. 2024 May 22. doi: 10.1007/s11357-024-01189-x. Online ahead of print. Geroscience. 2024. PMID: 38776043
-
Aging in Ocular Blood Vessels: Molecular Insights and the Role of Oxidative Stress.Biomedicines. 2024 Apr 8;12(4):817. doi: 10.3390/biomedicines12040817. Biomedicines. 2024. PMID: 38672172 Free PMC article. Review.
-
Investigating the Neuroprotective and Cognitive-Enhancing Effects of Bacopa monnieri: A Systematic Review Focused on Inflammation, Oxidative Stress, Mitochondrial Dysfunction, and Apoptosis.Antioxidants (Basel). 2024 Mar 25;13(4):393. doi: 10.3390/antiox13040393. Antioxidants (Basel). 2024. PMID: 38671841 Free PMC article. Review.
-
Not every organ ticks the same.Nat Rev Nephrol. 2024 Jul;20(7):431-432. doi: 10.1038/s41581-024-00842-0. Nat Rev Nephrol. 2024. PMID: 38658670 No abstract available.
References
-
- Alzheimer’s Association. 2019 Alzheimer’s disease facts and figures. Alzheimers Dement 2019;15:321–87.
-
- Masters CL, Bateman R, Blennow K, Rowe CC, Sperling RA, Cummings JL. Alzheimer’s disease. Nat Rev Dis Primers 2015;1:15056. - PubMed
-
- Herrington W, Lacey B, Sherliker P, Armitage J, Lewington S. Epidemiology of atherosclerosis and the potential to reduce the global burden of atherothrombotic disease. Circ Res 2016;118:535–46. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical